Skandinaviska Enskilda Banken (SEB)’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,500	Closed	-$119K	–	965
2023 Q3	$119K	Sell	15,500 -32,300	-68%	-$248K	﹤0.01%	859
2023 Q2	$358K	Sell	47,800 -400	-0.8%	-$3K	﹤0.01%	818
2023 Q1	$321K	Buy	+48,200	New	+$321K	﹤0.01%	800